Medical Treatments for Prostate CancerThere are many different medical treatments for prostate cancer that involve the clinical care of a healthcare professional. These treatments include expectant therapy, surgery, radiation therapy, hormone therapy, and chemotherapy. Expectant therapy is to carefully observe and monitor the prostate cancer. Because prostate cancer cells often spread very slowly, many older men who have the disease may not need more extensive treatment. However, expectant therapy usually includes routine physician examinations, including digital rectal exams and PSA tests. The different types of surgery for prostate cancer are radical prostatectomy - an open-surgery procedure in which the entire prostate gland and surrounding tissue are removed. Transurethral resection of the prostate (TURP) - surgery to remove part of the prostate gland that surrounds the urethra. Cryosurgery - this procedure involves killing the cancer cells by freezing them with a small metal tool placed in the tumor. Side effects of prostate cancer surgery include incontinence and impotence. Incontinence is the inability to control urine and may result in dribbling of urine, especially immediately after surgery. Normal control usually returns within weeks or months after surgery. Impotence is the inability to achieve an erection. For a month, or so, after surgery, most men are not able to get an erection. Eventually, approximately 40 to 60 percent of men will be able to get an erection sufficient for sexual intercourse, but without ejaculation of semen, since removal of the prostate gland prevents that process.Radiation therapy uses high energy rays to kill or shrink cancer cells, and to decrease their ability to divide. Radiation is often used to treat prostate cancer that is still confined to the prostate gland, or has spread only to nearby tissue. If the disease is advanced, radiation may be used to reduce the size of the tumor and to provide relief from symptoms. Possible side effects of radiation for prostate cancer may include diarrhea, with or without blood in the stool, and colitis, problems associated with urination, a degree of impotence (inability to get an erection), which may occur within two years of radiation therapy. The goal of hormone therapy is to lower the level of male hormones in the body, particularly testosterone. Hormone therapy does not cure the cancer, and is often used to treat persons whose cancer has spread or recurred after treatment. Produced mainly in the testicles, testosterone causes prostate cancer cells to grow. Thus, reduced testosterone levels can make the prostate cancer shrink and become less active. Most studies show that hormone therapy works better if it is started early. Chemotherapy is the use of powerful, anti-cancer medications to kill cancer cells.. Hospitalization may be needed to monitor treatment and chemotherapy's side effects. Common side effects of chemotherapy include: nausea and vomiting, hair loss, anemia, reduced ability of blood to clot, mouth sores, increased likelihood of developing infections, fatigue. Most side effects disappear once treatment is stopped. |
| carcinomatosis prostate |
|
Eurekah - Hyperthermia and Radiotherapy in the Management of Carcinoma of the prostate has been included in the top five big killer neoplasms at Peritoneal carcinomatosis may present as synchronous disease or like Blackwell Synergy - Prostate J, Volume 2 Issue 4 Page 233-237 Meningeal carcinomatosis, in prostate cancer, 1:99. β-Microseminoprotein, 2:94. Milk, 1:1. Muscular atrophy, spinal and bulbar, 2:14 Leptomeningeal carcinomatosis in a patient with metastatic Leptomeningeal carcinomatosis in a patient with metastatic prostate cancer: case report and literature review. Lawrence A CONE, Kamran KOOCHEK, The American Journal of the Medical Sciences - Fulltext: Volume Wu JW, Chiles C. Lymphangitic carcinomatosis from prostate carcinoma. J Comput Assist Tomogr 1999;23:761-3. Fulltext Link CrossRef Context Link Neurologic Complications of Prostate Cancer - May 1, 2002 Leptomeningeal carcinomatosis, the most frequent form of brain metastasis in prostate cancer, has a grim prognosis. Because neurologic complications of UCLA Department of Medicine - wfsection-An Unusual Case of Legge DA, Good CA, Ludwig J. Roentgenologic features of pulmonary carcinomatosis from carcinoma of the prostate. Am J Roentgenol Radium Ther Nucl Med. Unbound MEDLINE | Solitary peritoneal carcinomatosis in prostate Unbound MEDLINE | Solitary peritoneal carcinomatosis in prostate cancer. Journal article. Search by keyword, journal, author or by EBM filters diagnosis, British Library Direct: Solitary Peritoneal Carcinomatosis in Solitary Peritoneal Carcinomatosis in Prostate Cancer. Author. Brehmer, B. Makris, A. Wellmann, A. Jakse, G. Journal title. AKTUELLE UROLOGIE Journal of Computer Assisted Tomography - Fulltext: Volume 23(5 Lymphangitic Carcinomatosis from Prostate Carcinoma. Thoracic And Breast Imaging: Clinical Image. Wu, John W.; Chiles, Caroline eMedicine - Lymphangitic Carcinomatosis : Article by Ali Nawaz Wu JW, Chiles C: Lymphangitic carcinomatosis from prostate carcinoma. J Comput Assist Tomogr 1999 Sep-Oct; 23(5): 761-3Medline. Yamamoto T, Nakane T, Solitary peritoneal carcinomatosis in prostate cancer In a transperitoneal approach for laparoscopic pelvic lymphadenectomy a peritoneal carcinomatosis from prostate cancer was proven. ROENTGENOLOGIC FEATURES OF PULMONARY CARCINOMATOSIS FROM CARCINOMA Anatomic. Pathology. (Dr. Ludwig). FEBRUARY,. 1971. 360. ROENTGENOLOGIC. FEATURES. OF. PULMONARY. CARCINOMATOSIS. FROM. CARCINOMA. OF. THE. PROSTATE* ROENTGENOLOGIC FEATURES OF PULMONARY CARCINOMATOSIS FROM CARCINOMA ROENTGENOLOGIC FEATURES OF PULMONARY CARCINOMATOSIS FROM CARCINOMA OF THE PROSTATE. DAVID A LEGGE, C ALLEN GOOD, JURGEN LUDWIG ajronline 111:22, 360-364, Prostatic meningeal carcinomatosis with low serum level of Prostatic meningeal carcinomatosis with low serum level of prostate-specific antigen. Honda M, Miyagawa I. Department of Urology, Faculty of Medicine, Lymphangitic carcinomatosis from prostate carcinoma. Lymphangitic carcinomatosis from prostate carcinoma. Wu JW, Chiles C. Department of Radiology, Wake Forest University School of Medicine, Winston-Salem, Secondary solid neoplasms of the prostate: a clinico-pathological Carcinomatosis; solitary nodule in prostate. Small cell carcinoma posterior prostate. 68. Breast. M. Carcinomatosis; small prostate. Adenocarcinoma ScienceDirect - Surgical Neurology : Leptomeningeal carcinomatosis 24 E. Reed, D. Matthews, V. Dyer and W.D. Figg, Meningeal carcinomatosis in metastatic prostate cancer: a case report, Prostate J 1 (1999), pp. 99â“102. The Journal of Urology : The Hemophagocytic Syndrome In Prostate 1 To our knowledge we report the first case of the hemophagocytic syndrome in prostate cancer revealed by disseminated carcinomatosis of the bone marrow. IngentaConnect Meningeal Carcinomatosis in Metastatic Prostate Meningeal Carcinomatosis in Metastatic Prostate Cancer: A Case Report. Authors: Reed, Eddie1; Matthews, Douglas1; Dyer, Valerie1; Figg, William D.1 |
| carcinomatosis prostate |
|
aggressive cancer prostate cancer hereditary prostate cancer prostate seed treatment dvd milking mistress prostate |